FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
-0.11%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$218M
AUM Growth
+$218M
(-6.4%)
Cap. Flow
-$4.96M
Cap. Flow
% of AUM
-2.27%
Top 10 Holdings %
Top 10 Hldgs %
99.53%
Holding
16
New
3
Increased
2
Reduced
6
Closed
3
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$5.24M |
| 2 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$1.01M |
| 3 |
Akebia Therapeutics
AKBA
|
$719K |
| 4 |
Sangamo Therapeutics
SGMO
|
$405K |
| 5 |
Ardelyx
ARDX
|
$191K |
Top Sells
| 1 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$3.94M |
| 2 |
NVET
Nexvet Biopharma plc Ordinary Shares
NVET
|
$3.41M |
| 3 |
DERM
Dermira, Inc.
DERM
|
$1.46M |
| 4 |
Larimar Therapeutics
LRMR
|
$1.16M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$882K |
Sector Composition
| 1 | Healthcare | 20.31% |
